Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-laboratory products.
086820 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086820008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시
- Website:
- https://bio-solution.co.kr/
- Sector:
- Manufacturing
Description
Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-07 00:00 |
투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포치료제)의 미국 2상 임상시험 최종결과보고서 수…
|
Korean | 13.1 KB | ||
| 2025-04-29 00:00 |
투자판단관련주요경영사항 (카티라이프(바솔자가연골유래연골세포)의 한국 식품의약품안전처 품목 변경허가 획득)
|
Korean | 9.5 KB | ||
| 2025-03-28 00:00 |
정기주주총회결과
|
Korean | 24.7 KB | ||
| 2025-03-28 00:00 |
[기재정정]사업보고서 (2024.12)
|
Korean | 1.3 MB | ||
| 2025-03-28 00:00 |
주식매수선택권부여에관한신고
|
Korean | 16.1 KB | ||
| 2025-03-20 00:00 |
감사보고서제출
|
Korean | 18.4 KB | ||
| 2025-03-20 00:00 |
사업보고서 (2024.12)
|
Korean | 520.1 KB | ||
| 2025-03-18 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 24.3 KB | ||
| 2025-03-13 00:00 |
주주총회소집결의
|
Korean | 13.6 KB | ||
| 2025-03-13 00:00 |
주주총회소집공고
|
Korean | 136.7 KB | ||
| 2025-03-13 00:00 |
의결권대리행사권유참고서류
|
Korean | 117.2 KB | ||
| 2025-03-13 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.9 KB | ||
| 2025-03-05 00:00 |
투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포)의 제3상 최종 임상시험결과보고서 수령)
|
Korean | 15.1 KB | ||
| 2025-02-18 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청)
|
Korean | 10.3 KB | ||
| 2025-02-13 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.9 KB |
Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bio Solution Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
